Prospective observational study to assess the role of targeted agent Gefitinib as palliative treatment in residual, recurrent, and metastatic squamous cell carcinoma of head and neck
{{output}}
Background: Patients with advanced head and neck squamous cell carcinoma (HNSCC) remain at high risk of developing local recurrence and distant metastases. Some patients do respond well to treatment but still have residual diseas... ...
